HIV/AIDS
Promising new drug studied for HIV
Published in AIDS Weekly, April 16th, 2007
There is an urgent need for new antiretroviral drugs due to rates of failure in existing combination antiretroviral therapies. Rates of failure after six years are currently 21 per cent for treatment experienced patients and 11 per cent for those new to treatment.
The current study looked at the effectiveness of the new 'protease-inhibitor' darunavir, when used in conjunction with a boosting (low) dose of the existing antiretroviral drug ritonavir.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-04-16)
More Articles from AIDS Weekly
- HIV/AIDS
RAND study finds religiosity can be an important tool in preventing the spread of HIV-AIDS - HIV/AIDS
Rush researchers participate in worldwide AIDS initiative led by Imperial College London - Vaccine Safety
Jefferson scientists find rabies-based vaccine could be effective against HIV - Cancer Vaccines
Bavarian Nordic A/S presents annual results 2006 - HIV/AIDS
AIDS Healthcare Foundation Sues California Over Delay on Medi-Cal for HIV-Infected - HIV/AIDS
Avexa's apricitabine demonstrates broader range of activity against drug resistant HIV strains - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
